In agreement with our preliminary data using 3-methyl adenine, and our ER stress data showing increased Beclin1 expression, knock down of Beclin1 or of ATG5 suppressed, but did not completely abolish, tumor cell killing by the (ruxolitinib + lapatinib) drug combination (Figure 11B). Here, ATG5 is linked to neoplasm.